No abstract

referrals-deaths on the list) + liver disease mortality in Scotland) Results 1297 patients were identified. Patients from the least deprived areas of Scotland were significantly more likely to be referred for liver transplantation. Pearson Correlation co-efficient 0.987; p=0.002. (See figure 1).Those patients from the most deprived quintile were significantly less likely to be listed compared to the most affluent quintile. (OR=0.653; 95% CI 0.456-0.935; p=0.02). No significant differences were found when comparing the other quintiles to the least deprived group. We did find that those from the more affluent groups did have more severe liver disease by UKELD (ANOVA p=0.003) however there was no difference in those not listed due to being 'too unwell' across the groups (Chi-squared p=0.447). Number of hepatocellular carcinomas (HCC) were not significantly different across the groups (Chi-squared p=0.976)Those not listed due to high risk or recidivism (Chisquared p=0.066) and due to HCC outside criteria (Chisquared p=0.870) were similar across the SIMD groups.There was no difference in waiting times on the transplant list across the SIMD groups (ANOVA p=0.794)We found that in those patients transplanted (n=623) there was no significant difference in survival at two years when compared to the most affluent quintile. For example, when comparing the most deprived quintile (14 deaths at 2 years (26.9%) vs 6 (11.5%); OR=0.600; 95% CI 0.222-1.621; p=0.314). Discussion Those patients from more deprived areas of Scotland are less likely to be referred or listed for liver transplantation compared to most affluent groups. However, these differences don't continue when looking at survival posttransplant.

No abstract

rates are high in patients with existing colon pathology. Rates would reduce in certain groups with greater vigilance and use of chromoendoscopy.. Surveillance timeframes were often breached. Effective processes should reduce delays. . Bowel preparation was often poor. If these colonoscopies are not repeated, the decision should be recorded. . Some adenomas were overlooked while endoscopists focussed on large polyps. Early repeat colonoscopy should be considered after complicated procedures. . Photodocumentation was adequate in 44.4% of cases.Inadequate photos may be a marker for other shortcomings and repeat colonoscopy considered if caecal documentation is incomplete.These findings indicate that PCCRC rates could be reduced by up to 70% if avoidable factors are addressed. There is a need for quality improvement studies targeting these factors to quantify their impact on PCCRC rates.

30 days. European data are sparse. We aimed to define the readmission rate in Scotland and identify reasons and predictors for readmission. Methods Patients undergoing primary transplant with cirrhosis between January 2009 and December 2018 were included (n=639). Data were collected on patient and disease demographics and blood results at transplant and discharge. Differences between those readmitted and not readmitted at 30 days were assessed using Chi-squared or Mann-Whitney U tests. Survival was assessed using Kaplan-Meier analysis. Cox proportional hazards were used to predict readmissions. Results Patients were predominantly male (n=410; 64.2%) with a median age of 58.9 years (IQR 51.8-64.1) at transplant. The commonest aetiologies were alcohol-related liver disease (n=226; 35.4%), chronic viral hepatitis (n=111; 17.4%) and non-alcoholic fatty liver disease (n=104; 16.4%). 208 patients (32.6%) had a hepatocellular carcinoma. Patients had a median UKELD of 55 (52-59) and a median length of stay of 13 days (10-18). One year mortality was 4.1% (n=26).Readmission rates were: 30 days, 19.4% (n=124); 90 days, 30.6% (n=194); 1 year, 46.9% (n=300). Demographics and blood results were similar between those readmitted at 30 days and those not, although significant differences were haemoglobin (g/dL) at transplant (readmitted vs not readmitted) (105 vs. 111; p=0.02), urea (mmol/L) at discharge (7.5 vs 6.3; p=0.009), and creatinine (mmol/L) at discharge (80 vs 73; p=0.007).Readmission within 30 days post LT conferred a significantly higher 1-year mortality (10 (8.1%) vs. 16 (3.1%) (p=0.012) (OR=2.74; (95% CI 1.210-6.186)); and represented a significant survival disadvantage at 1 year in a Kaplan-Meier analysis (readmitted within 30 days: mean survival 348 days (95% CI 337-359) vs not readmitted within 30 days: mean survival 361 days (95% CI 358-363). Log rank p=0.01).The main reasons for admissions were deranged LFTs (34%; n=42), AKI (22%; n=27), and infection (18%; n=22).Significant differences on multivariate analysis were found for haemoglobin at transplant (HR=0.988 (95% CI 0.979-0.996); p=0.005) and creatinine at discharge (HR=1.006 (95% CI 1.003-1.010); p=0.001). Discussion In Scotland, readmission rates following LT were lower than in previously published, American, data. Haemoglobin and creatinine were predictors of readmission.Patients readmitted within 30 days of LT were more than twice as likely to die within 1 year.The commonest reasons for readmission were deranged LFTs, AKI and infection.